Second primary cancers in patients with laryngeal cancer: A population-based study

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 2, 2003, Pages 427-435

  Gao, Xiang ^a,d   Fisher, Susan G ^b   Mohideen, Najeeb ^c   Emami, Bahman ^c  

^a Ctrl AR Radiation Therapy Institute   (United States)

^b UNIVERSITY OF ROCHESTER   (United States)

^c LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF ARKANSAS SYSTEM   (United States)

Author keywords

Head and neck cancer; Prevention; Radiotherapy; Second malignancies

Indexed keywords

CHEMOTHERAPY; DATABASE SYSTEMS; RADIOTHERAPY; TUMORS;

LARYNGEAL CANCER;

ONCOLOGY;

ADULT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CONFIDENCE INTERVAL; DATA BASE; ESOPHAGUS CARCINOMA; GENDER; HEAD AND NECK CANCER; HUMAN; LARYNX CARCINOMA; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; SMOKING; TIME;

EID: 0038300433     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)04613-8     Document Type: Article

References (44)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. Cancer J Clin. 52:2002;23-47.
2. Burch J.D., Howe G.R., Miller A.B., et al. Tobacco, alcohol, asbestos, and nickel in the etiology of cancer of the larynx. A case-control study. J Natl Cancer Inst. 67:1981;1219-1224.
3. Koufman J.A., Burke A.J. The etiology and pathogenesis of laryngeal carcinoma. Otol Clin North Am. 30:1997;1-19.
4. Mulder T.P., Manni J.J., Roelofs H.M., et al. Glutathione S-transferases and glutathione in human head and neck cancer. Carcinogenesis. 16:1995;619-624.
5. Cloos J., Spitz M.R., Schantz S.P., et al. Genetic susceptibility to head and neck squamous cell carcinoma. J Natl Cancer Inst. 88:1996;530-535.
6. Boice J.D., Fraumeni J.F. Second cancer following cancer of the respiratory system in Connecticut, 1935-1982. Natl Cancer Inst Monogr. 68:1985;83-98.
7. Olsen J.H. Second cancer following cancer of the respiratory system in Denmark, 1943-1980. Natl Cancer Inst Monogr. 68:1985;309-324.
8. Nikolaou A., Markou C.D., Petridis D.G., et al. Second primary neoplasms in patients with laryngeal carcinoma. Laryngoscope. 110:2000;58-64.
9. Gluckman J.L., Crissman J.D. Survival rates in 548 patients with multiple neoplasms of the upper aerodigestive tract. Laryngoscope. 93:1983;71-74.
10. Lundgren J., Olofsson J. Multiple primary malignancies in patients treated for laryngeal carcinoma. J Otolaryngol. 15:1986;145-150.
11. Deviri E., Bartal A., Goldsher M., et al. Occurrence of additional primary neoplasms in patients with laryngeal carcinoma in Israel (1960-1976). Ann Otol Rhinol Laryngol. 91:1982;261-265.
12. Wagenfeld D.J.H., Harwood A.R., Bryce D.P., et al. Second primary respiratory tract malignancies in glottic carcinoma. Cancer. 46:1980;1883-1886.
13. Haughey B.H., Gates G.A., Arfken C.L., et al. Meta-analysis of second malignant tumors in the head and neck cancer The case for an endoscopic screening protocol . Ann Otol Rhinol Laryngol. 101:1992;105-112.
14. Narayana A., Vaughan A.T.M., Fisher S.G., et al. Second primary tumors in laryngeal cancer Results of long-term follow-up . Int J Radiat Oncol Biol Phys. 42:1998;557-562.
15. McDonald S., Haie C., Rubin P., et al. Second malignant tumors in patients with laryngeal carcinoma Diagnosis, treatment, and prevention . Int J Radiat Oncol Biol Phys. 17:1989;457-465.
16. Leon X., Quer M., Diez S., et al. Second neoplasm in patients with head and neck cancer. Head Neck. 21:1999;204-210.
17. Parker R.G., Enstrom J.E. Second primary cancers of the head and neck following treatment of initial primary head and neck cancers. Int J Radiat Oncol Biol Phys. 14:1988;561-564.
18. Jones A.S., Morar P., Phillips D.E., et al. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer. 75:1995;1343-1353.
19. Lawson W., Som M. Second primary cancer after irradiation of laryngeal cancer. Ann Otol. 84:1975;771-775.
20. McGuirt W.F., Ray M. Second laryngeal cancers in previously treated larynges. Laryngoscope. 109:1999;1406-1408.
21. Ries LA, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK, editors. SEER cancer statistics review, 1973-1996; tables and graphs. Bethesda, MD: National Cancer Institute; 1999. NIH Publ. No. 99-2789.
22. Percy C., van Holten V., Muir C. International classification of diseases for oncology. 2nd ed:1990;1-144 World Health Organization, Geneva, Switzerland.
23. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
24. Cox D.R. Regression models and life tables. J Royal Stat. 34:1972;187-229.
25. Slaughter D.P., Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer. 6:1953;963-968.
26. Chung K.Y., Mukhopadhyay T., Kim J., et al. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res. 53:1993;1676-1683.
27. Nees M., Homann N., Discher H., et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients A possible molecular basis for developing multiple tumors . Cancer Res. 53:1993;4189-4196.
28. Voravud N., Shin D.M., Ro J.Y., et al. Increased polysomies of chromosomes 7 and 17 during head and neck multistage tumorigenesis. Cancer Res. 53:1993;2874-2883.
29. Brandenberg J.H., Kellerman G. Aryl hydrocarbon hydroxylase inducibility in laryngeal carcinoma. Arch Otolaryngol. 104:1978;151-155.
30. Drozdz M., Gierek T., Jendryczko A., et al. N-acetyltransferase phenotype of patients with cancer of the larynx. Neoplasma. 34:1987;481-484.
31. Wu X., Gu J., Hong W.K., Lee J.J., et al. Benzo[a]pyrene diol epoxide and bleomycin sensitivity of lymphocytes and head and neck cancer susceptibility. J Natl Cancer Inst. 90:1998;1393-1399.
32. Spitz M.R., Hoque A., Trizna Z., et al. Mutagen sensitivity as a risk factor for second malignant tumors following upper aerodigestive tract malignancies. J Natl Cancer Inst. 86:1994;1681-1684.
33. Cloos J., Nieuwenhuis E.J.C., Boomsma D.I., et al. Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst. 91:1999;1125-1130.
34. Swerdlow A.J., Barber J.A., Horwich A., et al. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer. 75:1997;116-123.
35. Travis L.B., Curtis R.E., Storm H., et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst. 89:1997;1429-1439.
36. Greenspan F.S. Radiation exposure and thyroid cancer. JAMA. 237:1977;2089-2091.
37. Maxon H.R., Thomas S.R., Saenger E.L., et al. Ionizing irradiation and the induction of clinically significant disease in the thyroid gland. Am J Med. 63:1977;967-978.
38. Refetoff S., Harrison J., Karanfilski B.T., et al. Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. N Engl J Med. 292:1975;171-175.
39. Shore R.E., Woodard E., Hildreth N., et al. Thyroid tumors following thymus irradiation. J Natl Cancer Inst. 74:1985;1177-1184.
40. Vikram B., Strong E., Shan J.P., et al. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg. 6:1984;734-737.
41. Cooper J.S., Pajak T.F., Rubin P., et al. Second malignancies in patients who have head and neck cancer Incidence, effect on survival and implications based on the RTOG experience . Int J Radiat Oncol Biol Phys. 17:1989;449-456.
42. Hong W.K., Lippman S.M., Itri L.M., et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N Engl J Med. 323:1990;795-801.
43. Benner S.E., Pajak T.F., Lippman S.M., et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck Long-term follow-up . J Natl Cancer Inst. 84:1994;140-141.
44. Khuri F.R., Kim E.S., Lee J.J., et al. The impact of smoking status disease stage and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomakers Prev. 10:2001;823-829.